Dalvance 500 (Dalbavancin Vials) 500mg

Dalvance 500 is an injectable antibiotic used to treat bacterial infections. This 500mg vial provides broad-spectrum coverage for skin and soft tissue infections. Ideal for outpatient therapy, it offers convenient dosing. Suitable for adults and children where prescribed.

Strength

500mg

Pack Size

Storage

Ambient

Manufacturer / TM Owner

ALLERGAN USA, INC.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Dalvance 500 is commonly prescribed to treat serious bacterial infections such as skin and soft tissue infections. It may be used when other antibiotics are ineffective or not tolerated. Dalbavancin, the active ingredient, works against gram-positive bacteria. Always follow healthcare provider guidance for use.

Side Effects

After administration, Dalvance 500 begins working to reduce infection symptoms like redness, swelling, and pain. Patients may notice improved comfort within days. Some experience mild reactions at the injection site, such as warmth or redness. Effects vary by individual health and infection type.

Precautions & Warnings

Keep Dalvance 500 stored at room temperature away from moisture and heat. Do not use if the vial is damaged or the solution appears cloudy. Inform your healthcare provider about all medications and conditions before use. Avoid exposure to extreme temperatures during transport.

Avoid Interactions

Dalvance 500 may interact with other antibiotics or medications affecting blood clotting. Caution is advised when combining with drugs that prolong QT intervals. Alcohol use may increase side effects like dizziness. Always disclose your full medication list to your healthcare provider.

Frequently Asked Questions

Dalvance 500 is used to treat bacterial infections, particularly skin and soft tissue infections caused by certain gram-positive bacteria.

Dalvance 500 is given as an intravenous injection by a healthcare professional in a clinical setting.

Dalvance 500 requires a prescription and should only be purchased from licensed pharmacies or healthcare providers.

Common side effects may include nausea, headache, or reactions at the injection site like redness or swelling.

Consult your healthcare provider to determine if Dalvance 500 is appropriate during pregnancy or while breastfeeding.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.